• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD INC. CLEO INSULIN SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD INC. CLEO INSULIN SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 21-7231
Device Problems Detachment Of Device Component (1104); Fracture (1260)
Patient Problems Foreign Body In Patient (2687); No Information (3190)
Event Date 01/05/2016
Event Type  Injury  
Manufacturer Narrative
Customer has not yet returned the device to the manufacturer for device evaluation.When and if the device becomes available and is returned and evaluated the manufacturer will file a follow-up report detailing the results of the evaluation.
 
Event Description
Distributor reported on behalf of user facility that 1mm of the device "needle" detached during use and remained in the body of the patient.It is unknown if the "needle" component is referring to the small metal inserter needle or the plastic cannula on the administration set.This information has been requested from the reporter.The 1mm device fragment was removed from the patient through a small incision.Two stitches were required to close the incision.No further adverse effects to patient were reported.
 
Manufacturer Narrative
One used infusion site was returned for evaluation.The examination of the infusion site showed that the cannula had broken off at approximately 1mm where it was attached to the base of the site.Examination under microscopy showed that the cannula was slightly bent over on one side.The remaining length of cannula was not returned.The examination under microscopy showed no abnormalities in the cannula wall thickness.The investigation could not establish root cause, but did not find any evidence to show the issue was caused by an intrinsic defect in the product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEO INSULIN SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS MEDICAL ASD INC.
1265 grey fox road
st. paul MN 55112
Manufacturer (Section G)
SMITHS MEDICAL ASD, INC.
1265 grey fox rd.
st. paul MN 55112
Manufacturer Contact
michele seliga
1265 grey fox rd.
st. paul, MN 55112
7633833052
MDR Report Key5419259
MDR Text Key37776547
Report Number2183502-2016-00152
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K042172
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/09/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/28/2020
Device Model Number21-7231
Device Catalogue Number21-7231-24
Device Lot Number75X100
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/15/2016
Initial Date FDA Received02/09/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/15/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/28/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
-
-